Latest Health News

Micro-X has landed a $3.3 million order from the Malaysian Ministry of Health for its Rover Plus mobile X-ray units, marking a significant step in its Southeast Asian expansion. Delivery is set to begin in October 2025.

Select Harvests updates on its 2025 almond crop, revealing a slightly smaller harvest than forecast but a strong reduction in net debt and a promising 2026 bloom outlook.

Bank of Queensland announces a $170 million goodwill impairment in its retail banking unit for FY25, reflecting structural industry changes but maintaining strong cash earnings and capital ratios.

European Lithium Limited will lift its trading suspension on 3 October 2025 following the release of its Annual Financial Report, marking a key milestone for investors.

CONNEQT Health has disclosed significant revisions to its 2025 financial results, highlighting increased losses driven by a larger-than-expected fair value write-down on its inHealth investment and a heightened inventory provision.

Aurum Resources Limited has had its trading suspension lifted immediately following the lodgement of its annual financial report, allowing its shares to resume trading on the ASX.

Echo IQ reports a remarkable 153% increase in echocardiogram processing through its EchoSolv AS platform in the US, with a Mayo Clinic validation study nearing completion ahead of a critical FDA submission. The company is also advancing European market entry and strengthening its advisory team to accelerate global growth.

Orion Minerals Ltd has been reinstated to ASX quotation following the release of its 2025 annual report and a new capital raising announcement, ending its trading suspension.

Australian Unity Limited has opened a $101 million non-renounceable entitlement offer alongside a $160 million placement, aiming to strengthen its balance sheet and support ongoing acquisitions. The company also announced the appointment of Kelly Bayer Rosmarin as its next CEO, signaling a new chapter in leadership.

ImpediMed secures expanded insurance reimbursement for its SOZO platform, now covering over 301 million US lives and enhancing early detection of breast cancer-related lymphedema.

BPH Global Ltd will lift its trading suspension on 2 October 2025 following the lodgement of its annual financial report for the year ended 30 June 2025.

DGR Global Limited will have its trading suspension lifted on 2 October 2025 following the lodgement of its annual report, marking a key step back to market normalcy.